RE: Fear…18 Feb 2022 13:26
Most on here change from positive to negative then back again as news comes or fails to arrive. For us, we take what is known to be more or less correct and make our decision to stay or sell up on these facts.
The NAV is, give or take. 12p
The SP is 6.25p approx.
Making it very cheap stock to buy in theory.
Then everyone has their own cost average, which for those buying down to 6p from say 20p in some cases, must give them an average of between 7-8p which means they should cover their outlay eventually with ease.
For those who did not buy down to 6p and average around 12p they have to be patient until the SP recovers after the disposal of Leap.
An average above 12p means they have to be very very patient and tuck their Seedstock away for a long time or sell and take a loss.
Then those who have bought in recently or have an average of 6p stand to at least double their money.
So you make your mind whether to remain or get out and stop looking every hour or so.
The portfolio contains good companies in a new health sector who stand to grow and eventually IPO. Plus it has Leap which has its products being used by a lot of gaming firms and therefore should be growing in value daily and should have an increased NAV once its current financial standing is released. Until we know its true value, of which Seed holds 40% approx. we cannot be certain of any thing. Seed either continue to hold Leap if its value is growing steadily or dispose of it at the right price, giving it more capital to invest in new companies in the cannabis sector . If Leap is doing exceptionally, with a good daily increase in value, we could hold it a little longer, which we would favour. However we think 97.5% at a guess would favour an immediate disposal at the right price or an IPO if it is capable of going public at a good price, again we wait to see Leaps true current value.
Basic for you to decide upon J2300.